MX2009011421A - Derivados de ftalazina e isoquinolina con actividades moduladoras del receptor de la s1p. - Google Patents
Derivados de ftalazina e isoquinolina con actividades moduladoras del receptor de la s1p.Info
- Publication number
- MX2009011421A MX2009011421A MX2009011421A MX2009011421A MX2009011421A MX 2009011421 A MX2009011421 A MX 2009011421A MX 2009011421 A MX2009011421 A MX 2009011421A MX 2009011421 A MX2009011421 A MX 2009011421A MX 2009011421 A MX2009011421 A MX 2009011421A
- Authority
- MX
- Mexico
- Prior art keywords
- phthalazine
- receptor modulating
- isoquinoline derivatives
- modulating activities
- slp receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
Abstract
La invención se relaciona con novedosos compuestos heterocíclicos de la fórmula (I) en la que todas las variables son como se definen en la memoria descriptiva, en forma libre o en forma de sal, así como con su preparación, con su uso como medicamentos y con los medicamentos que los contienen.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07106753 | 2007-04-23 | ||
PCT/EP2008/054797 WO2008129029A1 (en) | 2007-04-23 | 2008-04-21 | Phthalazine and isoquinoline derivatives with slp receptor modulating activities |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009011421A true MX2009011421A (es) | 2009-12-15 |
Family
ID=38582125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009011421A MX2009011421A (es) | 2007-04-23 | 2008-04-21 | Derivados de ftalazina e isoquinolina con actividades moduladoras del receptor de la s1p. |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100179153A1 (es) |
EP (1) | EP2148863A1 (es) |
JP (1) | JP2010525016A (es) |
KR (1) | KR20100015857A (es) |
CN (1) | CN101679274A (es) |
AU (1) | AU2008240679A1 (es) |
BR (1) | BRPI0810123A2 (es) |
CA (1) | CA2684965A1 (es) |
EA (1) | EA200901389A1 (es) |
MX (1) | MX2009011421A (es) |
WO (1) | WO2008129029A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8466150B2 (en) * | 2006-12-28 | 2013-06-18 | Abbott Laboratories | Inhibitors of poly(ADP-ribose)polymerase |
WO2008083027A1 (en) * | 2006-12-28 | 2008-07-10 | Abbott Laboratories | Inhibitors of poly(adp-ribose)polymerase |
TW201206893A (en) * | 2010-07-09 | 2012-02-16 | Abbott Healthcare Products Bv | Bisaryl (thio) morpholine derivatives as S1P modulators |
TW201643169A (zh) | 2010-07-09 | 2016-12-16 | 艾伯維股份有限公司 | 作為s1p調節劑的螺-哌啶衍生物 |
TWI522361B (zh) | 2010-07-09 | 2016-02-21 | 艾伯維公司 | 作為s1p調節劑的稠合雜環衍生物 |
WO2012164103A2 (en) | 2011-06-03 | 2012-12-06 | Universität Zürich | Blockers of the nogo-a s1pr pathway for the treatment of diseases characterized by neuronal damage and lack of subsequent repair |
CN110291383B (zh) * | 2017-02-23 | 2021-12-28 | 株式会社Ihi | Oh自由基检测探测器、oh自由基测定装置以及oh自由基测定方法 |
JP2022553802A (ja) | 2019-10-31 | 2022-12-26 | エスケープ・バイオ・インコーポレイテッド | S1p受容体モジュレーターの固体形態 |
KR102541577B1 (ko) * | 2022-10-21 | 2023-06-13 | 주식회사 넥스트젠바이오사이언스 | S1pr1과 s1pr4에 대한 기능적 저해제로 작용하는 원형 탈모증의 예방 또는 치료용 약학적 조성물 |
AU2023248144A1 (en) | 2022-10-21 | 2024-05-09 | Nextgen Bioscience Co., Ltd. | Pharmaceutical composition for preventing or treating alopecia areata acting as a functional antagonist for s1pr1 and s1pr4 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2063249A (en) * | 1979-10-09 | 1981-06-03 | Mitsubishi Yuka Pharma | 4-Phenylphthalazine derivatives |
US6706731B2 (en) * | 2000-02-09 | 2004-03-16 | Novartis Ag | Pyridine derivatives inhibiting angiogenesis and/or VEGF receptor tyrosine kinase |
RU2167659C1 (ru) * | 2000-08-02 | 2001-05-27 | Закрытое акционерное общество "Центр современной медицины "Медикор" | Способ коррекции иммунной системы живого организма |
MXPA06002310A (es) * | 2003-08-29 | 2006-05-25 | Ono Pharmaceutical Co | Compuesto capaz de enlazarse al receptor s1p y uso farmaceutico del mismo. |
PL1689387T3 (pl) * | 2003-11-19 | 2012-02-29 | Array Biopharma Inc | Bicykliczne inhibitory MEK i sposoby ich otrzymywania |
CN102256948A (zh) * | 2008-10-20 | 2011-11-23 | H.隆德贝克有限公司 | 用作nk3拮抗剂的异喹啉酮衍生物 |
-
2008
- 2008-04-21 EP EP08749628A patent/EP2148863A1/en not_active Withdrawn
- 2008-04-21 JP JP2010504651A patent/JP2010525016A/ja active Pending
- 2008-04-21 US US12/597,100 patent/US20100179153A1/en not_active Abandoned
- 2008-04-21 EA EA200901389A patent/EA200901389A1/ru unknown
- 2008-04-21 AU AU2008240679A patent/AU2008240679A1/en not_active Abandoned
- 2008-04-21 KR KR1020097022224A patent/KR20100015857A/ko not_active Application Discontinuation
- 2008-04-21 WO PCT/EP2008/054797 patent/WO2008129029A1/en active Application Filing
- 2008-04-21 MX MX2009011421A patent/MX2009011421A/es not_active Application Discontinuation
- 2008-04-21 CA CA002684965A patent/CA2684965A1/en not_active Abandoned
- 2008-04-21 BR BRPI0810123-0A2A patent/BRPI0810123A2/pt not_active Application Discontinuation
- 2008-04-21 CN CN200880014650A patent/CN101679274A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2008129029A1 (en) | 2008-10-30 |
BRPI0810123A2 (pt) | 2014-10-29 |
EA200901389A1 (ru) | 2010-04-30 |
JP2010525016A (ja) | 2010-07-22 |
EP2148863A1 (en) | 2010-02-03 |
CN101679274A (zh) | 2010-03-24 |
AU2008240679A1 (en) | 2008-10-30 |
KR20100015857A (ko) | 2010-02-12 |
CA2684965A1 (en) | 2008-10-30 |
US20100179153A1 (en) | 2010-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009011421A (es) | Derivados de ftalazina e isoquinolina con actividades moduladoras del receptor de la s1p. | |
IN2012DN01269A (es) | ||
PH12012501905A1 (en) | Quinoline derivatives and their use as fungicides | |
NZ597517A (en) | 5-fluoropyrimidinone derivatives | |
UA107445C2 (uk) | 5-фторпіримідинові похідні як фунгіциди | |
IL204437A (en) | History of aryl cyclic profile and their use | |
TW200800968A (en) | Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs | |
NZ603151A (en) | N3-substituted-n1-sulfonyl-5-fluoropyrimidinone derivatives | |
TN2012000249A1 (en) | Pyrazine derivatives and their use in the treatment of neurological disorders | |
GEP201606555B (en) | Compounds and compositions for modulating egfr activity | |
MX2010009207A (es) | Compuestos y composiciones heterociclicos como inhibidores de c-kit y pdgfr cinasa. | |
MX2009010071A (es) | Derivados de aril isoxazolina insecticidas. | |
MX2011008864A (es) | Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales. | |
UA94639C2 (ru) | Трициклические соединения и их применение как модуляторов глюкокортикоидного рецептора | |
MX2009007713A (es) | Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas. | |
PT1877367E (pt) | Derivados do acetileno | |
MX348451B (es) | Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparación y su uso como antagonistas p2y12. | |
MX2012005559A (es) | Moduladores heterociclicos selectivos del receptor de esfingosina 1 fosfato. | |
NZ597483A (en) | N1-substituted-5-fluoro-2-oxopyrimidinone-1(2h)-carboxamide derivatives | |
NZ597570A (en) | N1-acyl-5-fluoropyrimidinone derivatives | |
MX2010001832A (es) | Composiciones para el cuidado domestico y de telas que comprenden complejos de colorante-polimero. | |
MX342947B (es) | Tratamiento de diabetes tipo 2. | |
MX2013006418A (es) | Derivados de oxazolil-metileter como agonistas del receptor de alx. | |
WO2008131946A3 (de) | Substituierte amid-derivate | |
MX2009000768A (es) | Lactamas macrociclicas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HH | Correction or change in general | ||
FA | Abandonment or withdrawal |